Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,874,253
-$218,526 QoQ
Shares Held
14,835
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#855
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $22,085,611 across 13 Drug Manufacturers - General names. GILD ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,989 | $5,983,956 | |
| 2 | ABBV |
AbbVie Inc.
|
20,064 | $5,048,904 | |
| 3 | JNJ |
Johnson & Johnson
|
7,437 | $1,888,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
14,835 | $1,874,253 | |
| 5 | AMGN |
Amgen Inc
|
4,952 | $1,793,218 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,268 | $1,704,938 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,945 | $1,149,230 | |
| 8 | SNY |
Sanofi
|
14,344 | $611,915 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,874,253 | 14,835 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,092,779 | 15,016 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,966,540 | 16,022 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $545,369 | 4,919 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $787,151 | 7,025 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $756,510 | 8,190 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $734,186 | 8,757 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $608,159 | 8,864 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $648,409 | 8,852 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $571,768 | 7,058 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $578,311 | 7,717 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $543,574 | 7,053 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $697,943 | 8,412 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,033,118 | 12,034 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $839,662 | 13,611 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $829,861 | 13,426 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $705,493 | 11,867 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $684,857 | 9,432 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $749,280 | 10,727 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $707,123 | 10,269 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $649,466 | 10,049 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $526,786 | 9,042 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $484,161 | 7,662 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $350,000 | 4,549 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $654,299 | 8,752 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||